Vivek Subbiah, Professor of Medicine at Stanford University School of Medicine, shared an update from Aditya Bardia, Professor of Medicine, on X, adding:
“Phenomenal meeting on antibody – drug conjugates state-of-the-art -cross‑tumor insights, deep dives into linker, payload, antibody engineering, and a truly energizing discussion on the future of ADC development. Huge thanks to Aditya Bardia for bringing this outstanding group together.”
Quoting Aditya Bardia:
“Excellent talk Vivek Subbiah on new ADC targets in oncology at the Inaugural Convergence Summit, Santa Monica, organized by TRIO-US and Pulse HS.”
Other articles about Aditya Bardia on OncoDaily.
